Cargando…
Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex‐deficient cancers
The SWI/SNF chromatin remodeling complex is composed of approximately 15 subunits, and approximately 20% of all cancers carry mutations in the genes encoding these subunits. Most of the genetic alterations in these genes are loss‐of‐function mutations. The identification of vulnerability based on sy...
Autores principales: | Sasaki, Mariko, Ogiwara, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060479/ https://www.ncbi.nlm.nih.gov/pubmed/31955490 http://dx.doi.org/10.1111/cas.14311 |
Ejemplares similares
-
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
por: Wanior, Marek, et al.
Publicado: (2021) -
Architecture of SWI/SNF chromatin remodeling complex
por: Zhang, Zhihui, et al.
Publicado: (2018) -
SWI/SNF Chromatin Remodeling Enzymes in Melanoma
por: Dreier, Megan R., et al.
Publicado: (2022) -
Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
por: Krishnamurthy, Nithya, et al.
Publicado: (2022) -
FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex
por: Lindén, Malin, et al.
Publicado: (2019)